安热沙、蜜丝婷防晒产品涉嫌假冒 近期，国家药品监督管理局最新发布的化妆品抽检信息显示，共有45批次化妆品不符合规定，其中涉及 防晒类产品14批次。值得注意的是，2批次知名防晒品牌安热沙、1批次蜜丝婷均被检出防晒霜成分不合 格，且3款产品经鉴别涉嫌系假冒产品。此外，另有11批次防晒产品检出不合格，主要问题集中在缺失 标示防晒剂、添加未标识成分、关键成分含量不足三方面。 抽检信息显示，标称株式会社资生堂生产、资生堂（中国）投资有限公司经销/境内责任人的"安热沙金 灿倍护防晒乳（90ml，标示批号5008L0）"、"安热沙金灿倍护防晒乳（60ml，标示批号5023D7）"检出 不合格。 这两款产品均标示上海（日本进口），普通化妆品备案编号J20200625，不合格原因系未检出标签及注 册资料中标示的多种防晒剂，具体包括双-乙基己氧苯酚甲氧苯基三嗪、二乙氨羟苯甲酰基苯甲酸己 酯、甲氧基肉桂酸乙基己酯、水杨酸乙基己酯、奥克立林等成分。 对此，产品境内责任人资生堂（中国）投资有限公司迅速提出样品真实性异议。经上海市药品监督管理 局核查确认，该企业并未生产或进口过该两批次抽检产品，相关产品涉嫌假冒。对于问题产品的后续处 理 ...

Summary of Key Points Core Viewpoint The Ningxia Hui Autonomous Region Drug Administration has announced the results of cosmetic quality inspections for 2025, revealing that out of 100 batches tested, 99 were compliant while 1 was found to be non-compliant. The authorities have taken necessary actions against the non-compliant product. Group 1: Inspection Results - A total of 100 batches of cosmetics were sampled in 2025, including 3 batches of facial masks, 9 batches of general skincare, 23 batches of children's skincare, 20 batches of hair dye, 30 batches of shampoo and cleansing products, and 15 batches claiming acne treatment [2]. - Out of the 100 batches tested, 99 were found to be compliant with quality standards, while only 1 batch was non-compliant [2]. Group 2: Regulatory Actions - The Ningxia Drug Administration has implemented risk control measures such as sealing, confiscating, and suspending sales of the non-compliant cosmetic product [2]. - Legal actions are being pursued against the non-compliant product as per the regulations [2].